RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro
Karen A Sutherland(University of Aberdeen), Michael J. Rogers(University of Aberdeen)
Cited by 48
Related Papers
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
|Proceedings of the National Academy of Sciences|2009|325
Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo
|Journal of Bone and Mineral Research|2009|163
Alkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathway
|Blood|2005|87
Antagonistic Effects of Different Classes of Bisphosphonates in Osteoclasts and Macrophages In Vitro
|Journal of Bone and Mineral Research|2003|77
Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases
|Immunology and Cell Biology|2016|47